Validation and Test Characteristics of a 10-Item Neuro-Ophthalmic Supplement to the NEI-VFQ-25

American Journal of Ophthalmology

Volumn 142, Issue 6, 2006, Pages

  Raphael, Brian A ^a   Galetta, Kristin M ^a   Jacobs, Dina A ^a   Markowitz, Clyde E ^a   Liu, Grant T ^a   Nano Schiavi, M Ligia ^a   Galetta, Steven L ^a   Maguire, Maureen G ^a   Mangione, Carol M ^b   Globe, Denise R ^c   Balcer, Laura J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 ITEM NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE; ADULT; ARTICLE; BINOCULAR VISION; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETIC RETINOPATHY; ENDOCRINE OPHTHALMOPATHY; FEMALE; FUNCTIONAL ASSESSMENT; HEALTH SURVEY; HUMAN; INTERNAL CONSISTENCY; INTRACRANIAL HYPERTENSION; ISCHEMIC OPTIC NEUROPATHY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; NEUROOPHTHALMOLOGY; OPHTHALMOPLEGIA; OPTIC NEURITIS; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; RELIABILITY; RISK ASSESSMENT; SCORING SYSTEM; SELF REPORT; STROKE; VALIDATION PROCESS; VISION; VISION TEST; VISUAL ACUITY; VISUAL DISORDER;

EID: 33845200582     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2006.06.060     Document Type: Article

References (42)

1. Balcer L.J. Multiple sclerosis and related demyelinating diseases. In: Miller N.R., Newman N.J., Biousse V., and Kerrison J.B. (Eds). Walsh and Hoyt's clinical neuro-ophthalmology. 6th ed. (2005), Williams & Wilkins, Baltimore, Maryland 3429-3525
2. Ma S.L., Shea J.A., Galetta S.L., et al. Self-reported visual dysfunction in multiple sclerosis: new data from the VFQ-25 and development of an MS-specific vision questionnaire. Am J Ophthalmol 133 (2002) 686-692
3. Cole S.R., Beck R.W., Moke P.S., Gal R.L., Long D.T., and Optic Neuritis Study Group. The National Eye Institute Visual Function Questionnaire: experience of the ONTT: Optic Neuritis Treatment Trial. Invest Ophthalmol Vis Sci 41 (2000) 1017-1021
4. Cleary P.A., Beck R.W., Bourque L.B., Backlund J.C., and Miskala P.H. Visual symptoms after optic neuritis: results from the Optic Neuritis Treatment Trial. J Neuroophthalmol 17 (1997) 18-28
5. Balcer L.J., Baier M.L., Kunkle A.M., et al. Self-reported visual dysfunction in multiple sclerosis: results from the 25-Item National Eye Institute Visual Function Questionnaire (VFQ-25). Multiple Sclerosis 6 (2000) 382-385
6. Fischer J.S., LaRocca N.G., Miller D.M., Ritvo P.G., Andrews H., and Paty D. Recent developments in the assessment of quality of life in multiple sclerosis. Mult Scler 5 (1999) 251-259
7. Rudick R.A., Miller D., Clough J.D., Gragg L.A., and Farmer R.G. Quality of life in multiple sclerosis: comparison with inflammatory bowel disease and rheumatoid arthritis. Arch Neurol 49 (1992) 1237-1242
8. Patrick D.L., and Deyo R.A. Generic and disease-specific measures in assessing health status and quality of life. Med Care 27 (1989) S217-S232
9. Vickrey B.G., Hays R.D., Genovese B.J., Myers L.W., and Ellison G.W. Comparison of a generic to disease-targeted health-related quality-of-life measures for multiple sclerosis. J Clin Epidemiol 50 (1997) 557-569
10. Lee P.P., Spritzer K., and Hays R.D. The impact of blurred vision on functioning and well-being. Ophthalmology 104 (1997) 390-396
11. Parrish II R.K., Gedde S.J., Scott I.U., et al. Visual function and quality of life among patients with glaucoma. Arch Ophthalmol 115 (1997) 1447-1455
12. Scott I.U., Schein O.D., West S., Bandeen-Roche K., Enger C., and Folstein M.F. Functional status and quality-of-life measurement among ophthalmic patients. Arch Ophthalmol 112 (1994) 329-335
13. Schiffman R.M., Jacobsen G., and Whitcup S.M. Visual functioning and general health status in patients with uveitis. Arch Ophthalmol 119 (2001) 841-849
14. Pesudovs K., Garamendi E., Keeves J.P., and Elliott D.B. The Activities of Daily Vision Scale for cataract surgery outcomes: re-evaluating validity with Rasch analysis. Invest Ophthalmol Vis Sci 44 (2003) 2892-2899
15. Janz N.K., Wren P.A., Lichter P.R., et al. The Collaborative Initial Glaucoma Treatment Study: interim quality of life findings after initial medical or surgical treatment of glaucoma. Ophthalmology 108 (2001) 1954-1965
16. Massof R.W. Application of stochastic measurement models to visual function rating scale questionnaires. Ophthalmic Epidemiol 12 (2005) 103-124
17. Mangione C.M. The National Eye Institute 25-item visual function questionnaire (VFQ-25): Version 2000. Scoring Manual (2000). http://www.nei.nih.gov/resources/visionfunction/manual_cm2000.pdf Accessible at: www.nei.nih.gov/resources/visionfunction/manual_cm2000.pdf.
18. Mangione C.M., Berry S., Spritzer K., et al. Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons. Arch Ophthalmol 116 (1998) 227-233
19. Mangione C.M., Lee P.P., Pitts J., et al. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ): NEI-VFQ Field Test Investigators. Arch Ophthalmol 116 (1998) 1496-1504
20. Mangione C.M., Lee P.P., Gutierrez P.R., et al. Development of the 25-Item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 119 (2001) 1050-1058
21. Broman A.T., Muñoz B., West S.K., et al. Psychometric properties of the 25-Item NEI-VFQ in a Hispanic population: Proyecto VER. Invest Ophthalmol Vis Sci 42 (2001) 606-613
22. Maguire M. Complications of Age-Related Macular Degeneration Prevention Trial Research Group: baseline characteristics, the 25-Item National Eye Institute Visual Functioning Questionnaire, and their associations in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT). Am J Ophthalmol 111 (2004) 1307-1316
23. Globe D., Varma R., Azen S.P., et al. Psychometric performance of the NEI-VFQ-25 in visually normal Latinos: The Los Angeles Latino Eye Study. Invest Ophthalmol Vis Sci 44 (2003) 1470-1478
24. Globe D., Wu J., Azen S., and Varma R. The impact of visual impairment on self-reported visual functioning in Latinos. Ophthalmology 111 (2004) 1141-1149
25. Beck R.N., Gal R.W., Brodskey M.C., et al. Visual function more than 10 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. Am J Ophthalmol 137 (2004) 77-83
26. Kymes S.M., Walline J.J., Zadnik K., et al. Quality-of-life in Keratoconus. Am J Ophthalmol 138 (2004) 527-535
27. Deramo V.A., Cox T.A., Syed A.B., Lee P.P., and Fekrat S. Vision-related quality-of-life in people with central retinal vein occlusion using the 25-Item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 121 (2003) 1297-1302
28. Stelmack J.A., Stelmack T.R., and Massof R.W. Measuring low-vision rehabilitation outcomes with the NEI-VFQ-25. Invest Ophthalmol Vis Sci 43 (2002) 2859-2868
29. Nordmann J.P., Viala M., Sullivan K., Arnould B., and Bordeaux G. Psychometric validation of the National Eye Institute Visual Function Questionnaire: 25 (NEI VFQ-25) French version: in a population of patients treated for ocular hypertension and glaucoma. Pharmacoeconomics 22 (2004) 197-206
30. Suzukamo Y., Oshiki T., Yuzawa M., et al. Psychometric properties of the 25-Item National Eye Institute Visual Function Questionnaire (NEI VFQ-25): Japanese version. Health Quality Life Outcomes 3 (2005) 65
31. Balcer L.J., Baier M.L., Cohen J.A., et al. Contrast letter acuity as a visual component for the multiple sclerosis functional composite. Neurology 61 (2003) 1367-1373
32. Fisher J.B., Jacobs D.A., Markowitz C.E., et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology 113 (2006) 324-332
33. Kurtzke J.F. Rating neurological impairment in multiple sclerosis; an expanded disability status scale (EDSS). Neurology 33 (1983) 1444-1452
34. Bailey I.L., and Lovie J.E. New design principles for visual acuity letter charts. Am J Optom Physiol Opt 53 (1976) 740-745
35. Ferris F.L., Kassoff A., Bresnick G.H., and Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol 94 (1982) 91-96
36. Ferris III F.L., and Bailey I. Standardizing the measurement of visual acuity for clinical research studies: guidelines from the Eye Care Technology Forum. Ophthalmology 103 (1996) 181-182
37. Complications of Age-Related Macular Degeneration Prevention Trial (CAPT) research group. Manual of procedures (2000). http://www.med.upenn.edu/cpob/studies/documents/MOP_July_2000.EP.pdf July. Accessible at: www.med.upenn.edu/cpob/studies/documents/MOP_July_2000.EP.pdf.
38. Rubin G.S., Munoz B., Bandeen-Roche K., West S.K., and SEE project team. Monocular vs binocular visual acuity as measures of vision impairment and predictors of visual disability. Invest Ophthalmol Vis Sci 41 (2000) 3327-3334
39. Azen S.P., Varma R., Preston-Martin S., et al. Binocular visual acuity summation and inhibition in an ocular epidemiological study: the Los Angeles Latino Eye study. Invest Ophthalmol Vis Sci 43 (2002) 1742-1748
40. Bailey I.L., Bullimore M.S., Raasch T.W., and Taylor H.R. Clinical grading and the effects of scaling. Invest Ophthalmol Vis Sci 32 (1991) 422-432
41. Greenland S. Introduction to regression modeling. In: Rothman K.J., and Greenland S. (Eds). Modern epidemiology. 2nd ed. (1998), Lippincott-Raven, Philadelphia, Pennsylvania 401-432
42. West S.K., Rubin G.S., Broman A.T., et al. How does visual impairment affect performance on tasks of everyday life?. Arch Ophthalmol 120 (2002) 774-780